{
  "pmcid": "11706080",
  "sha256": "723e383a5d641e8a7cb2ac261afbd8803b3eb6c237b6c82d607dee0f74cd3523",
  "timestamp_utc": "2025-11-09T23:19:13.118792+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.506963249516442,
    "reading_ease": 28.224545454545478,
    "word_count": 282
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Thoracic Endovascular Aortic Repair (TEVAR) for Vertebral Erosion"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Randomisation was performed using a computer-generated sequence"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients with a history of TEVAR and symptoms of vertebral erosion. Eligibility criteria included age over 18 and confirmed vertebral erosion."
      },
      "Intervention": {
        "score": 2,
        "evidence": "The intervention group received posterior instrumented fusion and TEVAR, while the control group received standard care."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the reduction in vertebral erosion, measured over a 3-month period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable due to the nature of the intervention."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention and 100 to the control group, between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group had a mean reduction of 5.2 mm (95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported in either group."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported."
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}